MDM LAB

100% ACCURATE & RELIABLE LABORATORY # 9502246660.

MDMLAB Clinical Trials Laboratory Services NABL

MDMLAB – Your Trusted Clinical Trials Laboratory Partner in Hyderabad

mdmlab



Advancing Clinical Research with Precision Diagnostics and Rapid Turnaround

Welcome to MDMLAB, a cutting-edge clinical diagnostics and research laboratory headquartered in Hyderabad, India. We specialize in offering customized laboratory support services for clinical trials, catering to the needs of CROs, pharmaceutical sponsors, academic institutions, and healthcare startups.

With state-of-the-art infrastructure, NABL-accredited processes, and a dedicated team of scientists, we enable seamless execution of clinical research with a strong emphasis on accuracy, regulatory compliance, and scientific rigor.


Current Clinical Trials Focus: Ulcerative Colitis (UC)

MDMLAB is currently collaborating on clinical trials focused on Ulcerative Colitis, actively supporting research across Phases 2 to 6:

  • Phase 2 – Dose-ranging studies and early efficacy validation

  • Phase 3 – Multicenter large-scale trials for safety and efficacy

  • Phase 4 – Post-marketing safety monitoring and real-world data collection

  • Phase 5 – Comparative effectiveness and health economics

  • Phase 6 – Community-based longitudinal and patient-reported outcomes research

Our dedicated UC research team facilitates rapid biomarker validation, anti-inflammatory therapy monitoring, and microbiome-based analysis.


🧪 Comprehensive Clinical Trial Laboratory Services

🔬 End-to-End Clinical Trial Support:

  • Customized test panels per protocol

  • Protocol and SOP alignment

  • Support for ethics submissions and regulatory documentation

💉 Sample Collection & Management:

  • On-site and remote blood collection across time-points

  • Pre- and post-dosing sample collection and aliquoting

  • Cold chain logistics with storage at -20°C, -80°C, and LN2

  • Chain of custody and barcode tracking

🧫 Central Laboratory Capabilities:

Biochemistry:

  • Liver and kidney function tests

  • Electrolyte balance

  • Lipid and glucose metabolism panels

Hematology:

  • Complete blood count (CBC)

  • Clotting studies (PT, aPTT)

  • Reticulocyte and ESR testing

Immunology:

  • CRP, ANA, RF, IL-6, TNF-alpha profiling

  • Antibody titer tracking for vaccines or immune therapies

Molecular Diagnostics:

  • Real-time PCR and qPCR

  • Genotyping, gene expression, and SNP analysis

  • Next-generation sequencing (NGS) for target validation


⚙️ Infrastructure Built for Clinical Trial Success

  • NABL-certified facility with GLP & GCLP practices

  • 24/7 sample processing for high-throughput studies

  • Real-time data entry and automated reporting

  • LIMS with audit trails and encrypted cloud storage

All our processes are aligned with international standards including ICH-GCP, DCGI, EMA, and FDA regulations.


📍 Hyderabad Advantage – Speed, Reach, and Support

Our strategic location offers:

  • Immediate access to leading hospitals and trial sites

  • Integrated logistics for fast specimen transport

  • Cost-effective operations with nationwide reach

We ensure a 24-hour turnaround time for most routine trial investigations, enhancing decision-making speed for clinical partners.


🤝 Collaborate With MDMLAB

Whether you are a startup biotech firm conducting a proof-of-concept study, or a global CRO managing a multicenter Phase 3 trial, we offer:

  • Custom engagement models (per test/per patient)

  • Centralized reporting for multi-site studies

  • Dedicated project managers for streamlined coordination

  • Audit and inspection support

We currently serve a growing list of CROs, pharma sponsors, academic hospitals, and government agencies.


📊 Ulcerative Colitis Trial Timeline at MDMLAB

Phase Focus Area Timeline
2 Biomarker screening, protocol optimization Q1 2024
3 Sample collection, assay validation, interim reporting Q2–Q3 2024
4 Adverse event analysis, long-term safety profiles Q4 2024
5 Biosimilar comparison, real-world effectiveness metrics Q1 2025
6 Quality of life, PRO data, cost-utility evaluations Ongoing till 2026

🚀 Future Capabilities in the Pipeline

MDMLAB is constantly evolving to meet future demands. Expansion plans include:

  • Flow Cytometry – For immune profiling in IBD and oncology

  • AI-Driven Pathology – Digital image analysis for biopsy samples (future)

  • Longitudinal Biobanking – For translational medicine and future-genomics

  • Metabolomics & Proteomics – For biomarker discovery


🗣️ Testimonials

“MDMLAB helped us meet critical deadlines with real-time reporting and regulatory compliance.” – Global CRO Partner

“We value their expertise in IBD trials and their proactive communication at every trial milestone.” – Lead Scientist, UC Research Project


📥 Let’s Talk: Partner With MDMLAB

For proposal requests, trial onboarding, or lab partnership:

📧 Email: mdmlab@mdmresearch.com
🌐 Website: www.mdmlab.in Cont: 9502246660
📍 Location: Hyderabad, Telangana, India


MDMLAB – Accelerating Clinical Innovation Through Diagnostics.

MDMLAB.IN


Verification: 5711b7ba1ef79345

Post a Comment

0 Comments